Article Details

Drug regulator's nod sought for third phase study of intranasal Covid vaccine in 5-18 age group

Retrieved on: 2022-09-11 07:23:22

Tags for this article:

Click the tags to see associated articles and topics

Drug regulator's nod sought for third phase study of intranasal Covid vaccine in 5-18 age group. View article details on hiswai:

Excerpt

Covid, Coronavirus, Covid vaccine, Monoclonal antibody therapy ... "Being an intranasal vaccine, BBV154 may produce local antibodies in the upper ...

Article found on: www.newindianexpress.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up